411 related articles for article (PubMed ID: 22240342)
1. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice.
Ma WJ; Bao MJ; Zhu JP; Yao HY; Xie YC; Guan Y; Li FF; Dong XW; Zheng YM; Xie QM
Vaccine; 2012 Feb; 30(8):1437-44. PubMed ID: 22240342
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of allergen extracts from Dermatophagoides farinae desensitizes specific allergen-induced inflammation and airway hyperresponsiveness in rats.
Xie QM; Wu X; Wu HM; Deng YM; Zhang SJ; Zhu JP; Dong XW
Int Immunopharmacol; 2008 Dec; 8(12):1639-45. PubMed ID: 18721904
[TBL] [Abstract][Full Text] [Related]
3. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.
Brimnes J; Kildsgaard J; Jacobi H; Lund K
Clin Exp Allergy; 2007 Apr; 37(4):488-97. PubMed ID: 17430344
[TBL] [Abstract][Full Text] [Related]
5. Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma.
Moerch U; Haahr Hansen M; Vest Hansen NJ; Rasmussen LK; Oleksiewicz MB; Frandsen TP; Haurum JS; Bregenholt S
Int Arch Allergy Immunol; 2006; 140(3):261-9. PubMed ID: 16699287
[TBL] [Abstract][Full Text] [Related]
6. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
7. Preventive effects of oral tolerance on allergic inflammation and airway remodeling in a murine model.
Kim SJ; Shin JH; Kim SC; Park CK; Kim SW
Am J Rhinol Allergy; 2013 Jan; 27(1):e11-6. PubMed ID: 23406589
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.
Marazuela EG; Rodríguez R; Fernández-García H; García MS; Villalba M; Batanero E
Mol Immunol; 2008 Jan; 45(2):438-45. PubMed ID: 17662454
[TBL] [Abstract][Full Text] [Related]
9. Shorter dosing intervals of sublingual immunotherapy lead to more efficacious treatment in a mouse model of allergic inflammation.
Rask C; Brimnes J; Lund K
Scand J Immunol; 2010 Jun; 71(6):403-12. PubMed ID: 20500692
[TBL] [Abstract][Full Text] [Related]
10. Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides.
Hufnagl K; Focke M; Gruber F; Hufnagl P; Loupal G; Scheiner O; Wiedermann U
Clin Exp Allergy; 2008 Jul; 38(7):1192-202. PubMed ID: 18462454
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic intranasal treatment with fragments of 1,3-beta-glucanase olive pollen allergen prevents airway inflammation in a murine model of type I allergy.
Palomares O; Batanero E; Cañamero M; Villalba M; Rodríguez R
Int Arch Allergy Immunol; 2006; 139(3):175-80. PubMed ID: 16439855
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
[TBL] [Abstract][Full Text] [Related]
14. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse.
Delayre-Orthez C; de Blay F; Frossard N; Pons F
Clin Exp Allergy; 2004 Nov; 34(11):1789-95. PubMed ID: 15544606
[TBL] [Abstract][Full Text] [Related]
17. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
19. Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy.
Weigmann B; Schughart N; Wiebe C; Sudowe S; Lehr HA; Jonuleit H; Vogel L; Becker C; Neurath MF; Grabbe S; Saloga J; Bellinghausen I
J Allergy Clin Immunol; 2012 Apr; 129(4):1126-35. PubMed ID: 22236728
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
